Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ALLELIC VARIANT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hiratsuka, M; Mizugaki, M
      Genetic polymorphisms in drug-metabolizing enzymes and drug targets

      MOLECULAR GENETICS AND METABOLISM
    2. Kuehl, P; Zhang, J; Lin, Y; Lamba, J; Assem, M; Schuetz, J; Watkins, PB; Daly, A; Wrighton, SA; Hall, SD; Maurel, P; Relling, M; Brimer, C; Yasuda, K; Venkataramanan, R; Strom, S; Thummel, K; Boguski, MS; Schuetz, E
      Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

      NATURE GENETICS
    3. Eiselt, R; Domanski, TL; Zibat, A; Mueller, R; Presecan-Siedel, E; Hustert, E; Zanger, UM; Brockmoller, J; Klenk, HP; Meyer, UA; Khan, KK; He, YA; Halpert, JR; Wojnowski, L
      Identification and functional characterization of eight CYP3A4 protein variants

      PHARMACOGENETICS
    4. van der Weide, J; Steijns, LSW; van Weelden, MJM; de Haan, K
      The effect of genetic polymorphism of cytochrome P450CYP2C9 on phenytoin dose requirement

      PHARMACOGENETICS
    5. Gellner, K; Eiselt, R; Hustert, E; Arnold, H; Koch, I; Haberl, M; Deglmann, CJ; Burk, O; Buntefuss, D; Escher, S; Bishop, C; Koebe, HG; Brinkmann, U; Klenk, HP; Kleine, K; Meyer, UA; Wojnowski, L
      Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene

      PHARMACOGENETICS
    6. Tabrizi, AR; McGrath, SD; Blinder, MA; Buchman, TG; Zehnbauer, BA; Freeman, BD
      Extreme warfarin sensitivity in siblings associated with multiple cytochrome P450 polymorphisms

      AMERICAN JOURNAL OF HEMATOLOGY
    7. Takahashi, H; Echizen, H
      Pharmacogenetics of warfarin elimination and its clinical implications

      CLINICAL PHARMACOKINETICS
    8. Scordo, MG; Aklillu, E; Yasar, U; Dahl, ML; Spina, E; Ingelman-Sundberg, M
      Genetic polymorphism of cytochrome P4502C9 in a Caucasian and a black African population

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    9. Linder, MW; Valdes, R
      Genetic mechanisms for variability in drug response and toxicity

      JOURNAL OF ANALYTICAL TOXICOLOGY
    10. Kim, JS; Nafziger, AN; Gaedigk, A; Dickmann, LJ; Rettie, AE; Bertino, JS
      Effects of oral vitamin K on S- and R-Warfarin pharmacokinetics and pharmacodynamics: Enhanced safety of warfarin as a CYP2C9 probe

      JOURNAL OF CLINICAL PHARMACOLOGY
    11. Leeder, JS
      Pharmacogenetics and pharmacogenomics

      PEDIATRIC CLINICS OF NORTH AMERICA
    12. Dickmann, LJ; Rettie, AE; Kneller, MB; Kim, RB; Wood, AJJ; Stein, CM; Wilkinson, GR; Schwarz, UI
      Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans

      MOLECULAR PHARMACOLOGY
    13. Aquaro, S; Menten, P; Struyf, S; Proost, P; Van Damme, J; De Clercq, E; Schols, D
      The LD78 beta isoform of MIP-1 alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages

      JOURNAL OF VIROLOGY
    14. Linder, MW
      Genetic mechanisms for hypersensitivity and resistance to the anticoagulant Warfarin

      CLINICA CHIMICA ACTA
    15. Bigler, J; Whitton, J; Lampe, JW; Fosdick, L; Bostick, RM; Potter, JD
      CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk

      CANCER RESEARCH
    16. Hutzler, JM; Frye, RF; Tracy, TS
      Sensitive and specific high-performance liquid chromatographic assay for 4'-hydroxyflurbiprofen and flurbiprofen in human urine and plasma

      JOURNAL OF CHROMATOGRAPHY B
    17. Yokozaki, H
      Distribution of germline BAT-40 poly-adenine tract microsatellite variantsin the Japanese

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    18. Brown, AF; McKie, MA
      MuStaR (TM) and other software for locus-specific mutation databases

      HUMAN MUTATION
    19. Aithal, GP; Day, CP; Leathart, JBS; Daly, AK
      Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis

      PHARMACOGENETICS
    20. Miners, JO; Coulter, S; Birkett, DJ; Goldstein, JA
      Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes

      PHARMACOGENETICS
    21. Nagata, K; Yamazoe, Y
      Pharmacogenetics of sulfotransferase

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    22. Proost, P; Menten, P; Struyf, S; Schutyser, E; De Meester, I; Van Damme, J
      Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78 beta into a most efficient monocyte attractant and CCR1 agonist

      BLOOD
    23. Gill, HJ; Tjia, JF; Kitteringham, NR; Pirmohamed, M; Back, DJ; Park, BK
      The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation

      PHARMACOGENETICS
    24. Crespi, CL; Miller, VP
      The use of heterologously expressed drug metabolizing enzymes - state of the art and prospects for the future

      PHARMACOLOGY & THERAPEUTICS
    25. Ozawa, S; Schoket, B; McDaniel, LP; Tang, YM; Ambrosone, C; Kostic, S; Vincze, I; Kadlubar, FF
      Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases

      CARCINOGENESIS
    26. McCrea, JB; Cribb, A; Rushmore, T; Osborne, B; Gillen, L; Lo, MW; Waldman, S; Bjornsson, T; Spielberg, S; Goldberg, MR
      Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    27. Nelson, DR
      Cytochrome P450 and the individuality of species

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    28. Biagini, CP; Philpot, RM; Celier, CM
      Nonsubstrate recognition site residues are involved in testosterone hydroxylation by cytochrome P450 CYP 2C11

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    29. TAKAHASHI H; KASHIMA T; NOMOTO S; IWADE K; TAINAKA H; SHIMIZU T; NOMIZO Y; MURAMOTO N; KIMURA S; ECHIZEN H
      COMPARISONS BETWEEN IN-VITRO AND IN-VIVO METABOLISM OF (S)-WARFARIN -CATALYTIC ACTIVITIES OF CDNA-EXPRESSED CYP2C9, ITS LEU(359) VARIANT AND THEIR MIXTURE VERSUS UNBOUND CLEARANCE IN PATIENTS WITH THE CORRESPONDING CYP2C9 GENOTYPES

      Pharmacogenetics
    30. GRIESE EU; ZANGER UM; BRUDERMANNS U; GAEDIGK A; MIKUS G; MORIKE K; STUVEN T; EICHELBAUM M
      ASSESSMENT OF THE PREDICTIVE POWER OF GENOTYPES FOR THE IN-VIVO CATALYTIC FUNCTION OF CYP2D6 IN A GERMAN POPULATION

      Pharmacogenetics
    31. Leathart, JBS; London, SJ; Steward, A; Adams, JD; Idle, JR; Daly, AK
      CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles

      PHARMACOGENETICS
    32. MINERS JO; BIRKETT DJ
      CYTOCHROME P4502C9 - AN ENZYME OF MAJOR IMPORTANCE IN HUMAN DRUG-METABOLISM

      British journal of clinical pharmacology
    33. TAKAHASHI H; KASHIMA T; NOMIZO Y; MURAMOTO N; SHIMIZU T; NASU K; KUBOTA T; KIMURA S; ECHIZEN H
      METABOLISM OF WARFARIN ENANTIOMERS IN JAPANESE PATIENTS WITH HEART-DISEASE HAVING DIFFERENT CYP2C9 AND CYP2C19 GENOTYPES

      Clinical pharmacology and therapeutics
    34. YAMAZAKI H; INOUE K; CHIBA K; OZAWA N; KAWAI T; SUZUKI Y; GOLDSTEIN JA; GUENGERICH FP; SHIMADA T
      COMPARATIVE-STUDIES ON THE CATALYTIC ROLES OF CYTOCHROME-P450-2C9 ANDITS CYS-VARIANTS AND LEU-VARIANTS IN THE OXIDATION OF WARFARIN, FLURBIPROFEN, AND DICLOFENAC BY HUMAN LIVER-MICROSOMES

      Biochemical pharmacology
    35. LASKER JM; WESTER MR; ARAMSOMBATDEE E; RAUCY JL
      CHARACTERIZATION OF CYP2C19 AND CYP2C9 FROM HUMAN LIVER - RESPECTIVE ROLES IN MICROSOMAL TOLBUTAMIDE, S-MEPHENYTOIN, AND OMEPRAZOLE HYDROXYLATIONS

      Archives of biochemistry and biophysics
    36. SAITOH E; MINAGUCHI K; ISHIBASHI O
      PRODUCTION AND CHARACTERIZATION OF 2 VARIANTS OF HUMAN CYSTATIN-SA ENCODED BY 2 ALLELES AT THE CST2 LOCUS OF THE TYPE-2 CYSTATIN GENE FAMILY

      Archives of biochemistry and biophysics
    37. TAKAHASHI H; KASHIMA T; KIMURA S; MURAMOTO N; NAKAHATA H; KUBO S; SHIMOYAMA Y; KAJIWARA M; ECHIZEN H
      DETERMINATION OF UNBOUND WARFARIN ENANTIOMERS IN HUMAN PLASMA AND 7-HYDROXYWARFARIN IN HUMAN URINE BY CHIRAL STATIONARY-PHASE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET OR FLUORESCENCE AND ONLINE CIRCULAR-DICHROISM DETECTION

      Journal of chromatography B. Biomedical sciences and applications
    38. STEWARD DJ; HAINING RL; HENNE KR; DAVIS G; RUSHMORE TH; TRAGER WF; RETTIE AE
      GENETIC ASSOCIATION BETWEEN SENSITIVITY TO WARFARIN AND EXPRESSION OFCYP2C9-ASTERISK-3

      Pharmacogenetics
    39. LONDON SJ; SULLIVANKLOSE T; DALY AK; IDLE JR
      LUNG-CANCER RISK IN RELATION TO THE CYP2C9 GENETIC-POLYMORPHISM AMONGCAUCASIANS IN LOS-ANGELES-COUNTY

      Pharmacogenetics
    40. NASU K; KUBOTA T; ISHIZAKI T
      GENETIC-ANALYSIS OF CYP2C9 POLYMORPHISM IN A JAPANESE POPULATION

      Pharmacogenetics
    41. ZHANG ZY; KERR J; WEXLER RS; LI HY; ROBINSON AJ; HARLOW PP; KAMINSKY LS
      WARFARIN ANALOG INHIBITION OF HUMAN CYP2C9-CATALYZED S-WARFARIN 7-HYDROXYLATION

      Thrombosis research
    42. CASSARDDOULCIER AM; BOUILLAUD F; CHAGNON M; GELLY C; DIONNE FT; OPPERT JM; BOUCHARD C; CHAGNON Y; RICQUIER D
      THE BCL-I POLYMORPHISM OF THE HUMAN UNCOUPLING PROTEIN (UCP) GENE IS DUE TO A POINT MUTATION IN THE 5'-FLANKING REGION

      International journal of obesity
    43. LINGE C; GEWERT D; ELLIS J; TUCKER D; ALLEN G; CROWE JS
      TRANSCRIPTION OF INTERFERON-ALPHA-2 ALLELES FROM VIRUS-INDUCED HUMAN-LEUKOCYTES AND LYMPHOBLASTOID-CELLS OF AFRICAN ORIGIN

      Biochimica et biophysica acta, N. Gene structure and expression
    44. MARSHALL VM; ANTHONY RL; BANGS MJ; PURNOMO; ANDERS RF; COPPEL RL
      ALLELIC VARIANTS OF THE PLASMODIUM-FALCIPARUM MEROZOITE SURFACE-ANTIGEN-2 (MSA-2) IN A GEOGRAPHICALLY RESTRICTED AREA OF IRIAN-JAYA

      Molecular and biochemical parasitology
    45. NAGAI S; YAGIHASHI T; ISHIHAMA A
      DNA-SEQUENCE ANALYSIS OF AN ALLELIC VARIANT OF THE ACTINOBACILLUS-PLEUROPNEUMONIAE-RTX-TOXIN-I (APXIA) FROM SEROTYPE-10

      Microbial pathogenesis
    46. VILSEN B
      A GLU(329)-] GLN VARIANT OF THE ALPHA-SUBUNIT OF THE RAT-KIDNEY NA-ATPASE CAN SUSTAIN ACTIVE-TRANSPORT OF NA+ AND K+ AND NA+,K+-ACTIVATED ATP HYDROLYSIS WITH NORMAL TURNOVER NUMBER(,K+)

      FEBS letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 22:48:30